Comorbidities, not age, are predictive of survival after autologous hematopoietic cell transplantation for relapsed/refractory Hodgkin's lymphoma in patients older than 50 years.
Martínez C, Jorge AS, Pereira A, Moreno M, Núñez J, Gayoso J, Gonzalez-Medina J, Revilla N, Sampol A, Domingo-Domenech E, de la Cruz F, Morales A, Rodriguez-Salazar MJ, Valiente S, Pérez-Ceballos E, de Oteyza JP, García-Sanz R; Hodgkin Lymphoma Subcommittee of Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO).
Martínez C, et al. Among authors: valiente s.
Ann Hematol. 2017 Jan;96(1):9-16. doi: 10.1007/s00277-016-2832-6. Epub 2016 Oct 18.
Ann Hematol. 2017.
PMID: 27752822